Our proactive approach to reducing costs includes:
Industry leading purchasing power accessing volume discounts and rebates.
Encouraging safe, effective, and less expensive drug alternatives by restricting coverage for non-essential medications.
Clinical expertise with innovating programs proven to strike the right balance between access and cost.
Guaranteeing appropriate lowest-cost equivalent drugs are tried prior to higher cost alternatives.